Showing 56,421 - 56,440 results of 56,725 for search '"medicine"', query time: 0.27s Refine Results
  1. 56421

    Effect of 5-Aminolevulinic Acid on the Quality and Volatile Metabolites of Korla Fragrant Pear Fruit by SUN Tianyu, WEN Bo, WANG Chunfeng, TIAN Jia, HAO Zhichao, LIN Yan, WEN Yue, ZHANG Feng

    Published 2024-12-01
    “…Among them, α-farnesene, 4-[((1E)-1,5-dimethyl-1,4-hexanedi-1-yl]-1-methyl-cyclohexene, δ-cadinene, (E)-1-methyl-4-(6-methylhept-5-en-2-ylidene) cyclohex-1-ene and germacrene B were annotated as key compounds to this pathway, which together endowed Korla fragrant pears with special citrus-like, lavender, lemony, astringent, thyme-like, spicy, earthy, non-medicinal and orange flower-like flavors. In conclusion, it is demonstrated that the exogenous application of 5-ALA significantly improved the quality of Korla fragrant pear fruit, the effect being most pronounced at 5-ALA concentration of 150 mg/L.…”
    Get full text
    Article
  2. 56422

    New methods of treatment for severe and moderate postoperative pain syndrome in patients with cancer by D.V. Dmytriiev, M.M. Barsa

    Published 2024-11-01
    “…Objective: to evaluate the clinical efficacy and safety of a medicinal product with active ingredient dinalbuphine sebacate (150 mg/2 ml) in patients with moderate to severe pain syndrome following reconstructive mammoplasty due to breast cancer surgery. …”
    Get full text
    Article
  3. 56423

    Anti-breast cancer activity of some novel quinoline derivatives by Ghorab Mostafa M., Alsaid Mansour S.

    Published 2015-09-01
    “…To discover new bioactive lead compounds for medicinal purposes, 2-cyano-3-(4-substituted)-N-(quinolin-3-yl) acrylamide derivatives 2–24, chromenes 25, 26 and benzochromenes 27, 28 were synthesized. …”
    Get full text
    Article
  4. 56424

    Mechanism of melanoma suppression by Prosopis juliflora derived alkaloids: Apoptosis induction and signaling pathway inhibition by Jasoda Choudhari, Snehal K. Nimal, Shridhar Chougule, Trupti Shinde, N.R. Dhatrak, Gopal C. Kundu, Rajesh N. Gacche

    Published 2025-02-01
    “…Background: Traditional medicines remain integral to healthcare worldwide especially in developing countries. …”
    Get full text
    Article
  5. 56425

    PHARMACEUTICAL CARE OF ACNE PATIENTS USING SYSTEMIC RETINOIDS by Yuliya Nastyukha, Andriy Zimenkovsky, Diana Klapko

    Published 2023-12-01
    “…The objects of the study: relevant information sources; current standards of pharmacotherapy, instructions for medical use of isotretinoin of the State Register of Medicines of Ukraine (n=4), 14th edition of the State Drug Formulary; questionnaires of acne patients who use systemic retinoids (n=53); pharmacy quotes for isotretinoin drugs and laboratory quotes for liver biopsy and lipid testing. …”
    Get full text
    Article
  6. 56426

    Severe subcutaneous infection with Clostridium septicum in a herd of native Icelandic horses by Charlotta Oddsdóttir, Ólöf G. Sigurðardóttir, Vala Friðriksdóttir, Vilhjálmur Svansson, Birkir Þór Bragason, Sigríður Björnsdóttir

    Published 2025-02-01
    “…Clostridial infections of equine muscle or subcutis following injection with medicinal products have been described in other countries but have never been reported in Iceland. …”
    Get full text
    Article
  7. 56427

    Multicentre adaptive randomised trial of GvHD prophylaxis following unrelated donor stem cell transplantation comparing Thymoglobulin versus calcineurin inhibitor-based or sirolimu... by Simon Gates, Matthew Collin, Victoria Potter, Rebecca Bishop, Ronjon Chakraverty, Kavita Raj, Adrian Bloor, Andrea Hodgkinson, Jeff Davies, Emma Kempshall, Fiona Dignan, Ram Malladi, Siobhan Smith, Charlotte Gaskell, Gabrielle Smith

    Published 2025-01-01
    “…Secondary outcomes include cumulative incidence of acute grade II-IV GvHD at 1 year, cumulative incidence of moderate and severe chronic GvHD at 1 year, overall survival at 1 year and cumulative incidence of non-relapse mortality at 1 year.Ethics and dissemination The protocol was approved by the West Midlands, Edgbaston Research Ethics Committee (20/WM/0195); initial approval was received on 11 September 2020, current protocol version (V.4.0) approval on 25 July 2023. The Medicines and Healthcare products Regulatory Authority also approved all protocol versions. …”
    Get full text
    Article
  8. 56428
  9. 56429
  10. 56430
  11. 56431
  12. 56432
  13. 56433
  14. 56434
  15. 56435
  16. 56436
  17. 56437
  18. 56438
  19. 56439
  20. 56440